SCHEMBL5283708

SCHEMBL5283708

CC(C)=N/N=c1\sc2ccccc2n1C(C)N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.42
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
HTT P42858 3/20 0.42
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
GAA P10253 2/20 0.37
LMNA P02545 2/20 0.36
ALDH1A1 P00352 5/20 0.36
ATM Q13315 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
F12 P00748 1/20 0.35
NPSR1 Q6W5P4 4/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283839 0.87 MAPT (0.43) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL4615776 0.80 KMT2A (0.51) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL5278396 0.77 MAPT (0.64) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5278390 0.77 MAPT (0.64) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL29774515 0.77 MAPT (0.64) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5282522 0.74 NPSR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5282524 0.74 NPSR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5281931 0.74 KMT2A (0.47) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5281927 0.74 KMT2A (0.47) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5283710 0.73 MAPT (0.44) MAPTNPC1RAB9ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885NPC1 4843/4885RAB9A 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.